The vascular NAD (P) H oxidases as therapeutic targets in cardiovascular diseases

H Cai, KK Griendling, DG Harrison - Trends in pharmacological sciences, 2003 - cell.com
… by these enzyme systems are common in cardiovascular disease. In the past several years,
… by these oxidases contribute to cardiovascular diseases including atherosclerosis and …

[HTML][HTML] SR-BI as target in atherosclerosis and cardiovascular disease-a comprehensive appraisal of the cellular functions of SR-BI in physiology and disease

M Hoekstra - Atherosclerosis, 2017 - Elsevier
… in the context of cardiovascular disease. The relative contribution … of atherosclerosis and
cardiovascular disease remains less clear, … that impact on cardiovascular disease susceptibility. …

[HTML][HTML] Cellular senescence in cardiac diseases

I Shimizu, T Minamino - Journal of cardiology, 2019 - Elsevier
… as age-related disease models [6], [7], [8]. In this review article, we would like to delineate
the role of cellular senescence and the related molecules in cardiac diseases, and discuss the …

Oxidative stress in cell death and cardiovascular diseases

T Xu, W Ding, X Ji, X Ao, Y Liu, W Yu… - … medicine and cellular …, 2019 - Wiley Online Library
… of cardiovascular diseases and is the clinical target during the disease treatment. Numerous
… the occurrence and development of the cardiovascular diseases. In this review, we …

Single-cell RNA sequencing to identify cellular heterogeneity and targets in cardiovascular diseases: from bench to bedside

X Xu, X Hua, H Mo, S Hu, J Song - Basic research in cardiology, 2023 - Springer
… mechanisms and assist in identifying potential therapeutic targets. In this review, … cellular
heterogeneity in cardiovascular homeostasis and diseases, and the discovery of CVD targets at …

Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications

J Steffel, TF Lüscher, FC Tanner - Circulation, 2006 - Am Heart Assoc
… attractive target for the treatment of cardiovascular diseases. … in the pathogenesis of
cardiovascular diseases. Therefore, … attractive target for the treatment of cardiovascular diseases. …

Targeting PPARα for the treatment and understanding of cardiovascular diseases

S Li, B Yang, Y Du, Y Lin, J Liu, S Huang… - Cellular Physiology and …, 2019 - karger.com
targets in cardiovascular diseases [49, 55, 56]. In this field, diverse approaches, such as …
Schematic of peroxisome proliferator-activated receptors-(PPARs) in cardiovascular diseases. …

The role of cellular senescence in cardiac disease: basic biology and clinical relevance

M Mehdizadeh, M Aguilar, E Thorin… - Nature Reviews …, 2022 - nature.com
… prevent and/or treat chronic cardiac disease and the safety of … role of cellular senescence
in cardiac disease potentially has … information linking cellular senescence to cardiac disease, …

Employment of targeted nanoparticles for imaging of cellular processes in cardiovascular disease

M Modak, MA Frey, S Yi, Y Liu, EA Scott - Current opinion in biotechnology, 2020 - Elsevier
… Here, we review recent advances in nanoparticle-mediated approaches for imaging of
cellular processes in cardiovascular disease, focusing on efforts to detect inflammation, assess …

Oxidative stress in cardiovascular diseases

E Dubois-Deruy, V Peugnet, A Turkieh, F Pinet - Antioxidants, 2020 - mdpi.com
Cardiovascular diseases comprise several disorders such as coronary artery diseases,
stroke, hypertension, heart failure, congenital heart diseases, and vascular diseases. The …